Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Long-Term Deferred Tax (2016 - 2025)

Mimedx (MDXG) has disclosed Long-Term Deferred Tax for 6 consecutive years, with $19.6 million as the latest value for Q4 2025.

  • Quarterly Long-Term Deferred Tax fell 30.77% to $19.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.6 million through Dec 2025, down 30.77% year-over-year, with the annual reading at $19.6 million for FY2025, 30.77% down from the prior year.
  • Long-Term Deferred Tax hit $19.6 million in Q4 2025 for Mimedx, down from $21.6 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $40.8 million in Q4 2023 to a low of $19.6 million in Q4 2025.
  • Historically, Long-Term Deferred Tax has averaged $29.8 million across 3 years, with a median of $28.3 million in 2024.
  • Biggest YoY gain for Long-Term Deferred Tax was 18.07% in 2025; the steepest drop was 30.77% in 2025.
  • Year by year, Long-Term Deferred Tax stood at $40.8 million in 2023, then plummeted by 30.58% to $28.3 million in 2024, then crashed by 30.77% to $19.6 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for MDXG at $19.6 million in Q4 2025, $21.6 million in Q3 2025, and $27.4 million in Q2 2025.